Increased numbers of double-negative (IgD−CD27−) memory B cells and a reduction in the number of naïve B cells (IgD+CD27−) in the peripheral blood have been identified in AD [30], and the number of cells producing antibodies targeting Aβ1-42 is increased in AD [31]. This evidence concerns the gene CD27 and Alzheimer disease.